Member Info for LordInvestor

Boom ... ! what is going on guys

....|
......./.\
...../__.\
.....|===|
.....|......|
.....|..N.|
.....|..N..|
.....|..S..|
.....|......|
.....|......|
.....|......|
.....|......|
.....|......|
..../|#||#|\
.../.|#||#|.\
../..|#||#|..\
..|../^||^\..|
..|./.^||^.\.|
..|/..^||^..\|
.....(VVV)
......(VV)
.......(V)
........*l*
......( * )
...( % : % )
.( %%:%%)
( % % % % )
(%%%.%%)

Update on new product development

The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd ("Volz"), has been approved by the UK's Medicines and Healthcare products Regulatory Agency ("MHRA"). The 5-ply mask has an additional filter layer, produced by Volz, after the hydrophobic outer layer, further strengthening the mask's already excellent bacterial filter efficiency.

The last year has established a close working relationship between Volz and the Company's subsidiary, Pharm 2 Farm Ltd ("P2F"). Not only is Volz manufacturing the existing 4-ply anti-viral masks for P2F, but the two companies have also been working on developing a new anti-viral filter material, as an extension of the work on the anti-viral mask and covered by the same patent. This new material has passed the proof-of-concept stage and Volz and P2F are now looking at how this could be commercialised (for example, in heating, ventilation and air conditioning systems), although this is expected to take several months, with work required on moving from proof-of-concept to large scale production.

Antony Legge, Executive Chairman, said; "Volz have been an excellent partner to Pharm 2 Farm, providing support in a number of areas. We are delighted with the MHRA approval for the 5-ply mask and to be working with Volz on an exciting development of the a-virion technology, with the potential to incorporate it into air filters."

If anyone that missed the news headline today.

Today’s headline news:

“Covid: Masks upgrade cuts infection risk, research finds”
https://www.bbc.co.uk/news/health-57636360

Sky news running a similar article also…
https://news.sky.com/story/covid-19-addenbrookes-hospital-upgraded-covid-staffs-face-masks-and-saw-cases-fall-by-almost-100-12344508

https://twitter.com/wizardbattery/status/1409706146194104332?s=21

RMS masks achieved EN14683 Certification and the RNS dated 22 January 2021 it was stated:
Bacterial Filtration Efficiency (BFE): this tests the filtration capacity of the mask. The P2F product achieved a 98.77%; higher than the 98% required and close to the 99% needed for FFP3 respirator.
The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd ("Volz"), has been approved by the UK's Medicines and Healthcare products Regulatory Agency ("MHRA"). The 5-ply mask has an additional filter layer, produced by Volz, after the hydrophobic outer layer, further strengthening the mask's already excellent bacterial filter efficiency.

The Company confirms that the Pharm 2 Farm Limited ("P2F") Pro Larva face mask (the "Pro Larva Mask") has been approved as a Class 1 medical device by the Medicines and Healthcare products Regulatory Agency ("MHRA").

Today’s headline news:

“Covid: Masks upgrade cuts infection risk, research finds”
https://www.bbc.co.uk/news/health-57636360

Sky news running a similar article also…
https://news.sky.com/story/covid-19-addenbrookes-hospital-upgraded-covid-staffs-face-masks-and-saw-cases-fall-by-almost-100-12344508

https://twitter.com/wizardbattery/status/1409706146194104332?s=21

RMS masks achieved EN14683 Certification and the RNS dated 22 January 2021 it was stated:
Bacterial Filtration Efficiency (BFE): this tests the filtration capacity of the mask. The P2F product achieved a 98.77%; higher than the 98% required and close to the 99% needed for FFP3 respirator.
The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd ("Volz"), has been approved by the UK's Medicines and Healthcare products Regulatory Agency ("MHRA"). The 5-ply mask has an additional filter layer, produced by Volz, after the hydrophobic outer layer, further strengthening the mask's already excellent bacterial filter efficiency.

The Company confirms that the Pharm 2 Farm Limited ("P2F") Pro Larva face mask (the "Pro Larva Mask") has been approved as a Class 1 medical device by the Medicines and Healthcare products Regulatory Agency ("MHRA").

WOW 1.45p now up 26%. What is going on it must be a leak of NHS contract.

yes, breaking out, 1.5p+ finish?

Wow 1.4p now. Boooom

Breakout testing 1.35p now. and going towards 2.2p
1.35 +0.20 (+17.39%)
Volume:
79,556,766
Bid/Ask:
1.30
/
1.35
Day's Range:
1.14 - 1.35

Ready to blow towards 2.2p
https://www.**********.co.uk/articles/bulletin-board-heroes-june-28-79593cb/

@maidit308

Do you have the link to zak mir podcast?

Please do your own research and you will see lobbying had been done to get RMS masks into NHS.

NHS Staff members are crying out for good masks. it was all over the news.

Well done everyone for holding. The buyers are flooding in.

It was giving me a price to sell the whole of my holding of £57K.

Price is rocketing now.

65.23 +4.23 +6.93%

This going to rocket with Visible gold with intersection of 7.2m at 258g/t gold

Does anyone know when the AVCT 5 mins Breathliser Testing results will be out?

Great product. will be a game changer.

https://www.lse.co.uk/rns/SKIN/unveiling-of-new-breath-testdigl-health-platform-yb7wzek8xmg4f2u.html

https://vimeo.com/461025771

Look at all the large buys. People have loaded up today.

They are going to go crazy buys at this silly price.

18-Feb-21 16:27:53 1.78 500,000 Buy* 1.70 1.80 8,900 O
18-Feb-21 16:26:30 1.75001 578,799 Buy* 1.70 1.80 10.13k O
18-Feb-21 16:25:29 1.75001 500,000 Buy* 1.70 1.80 8,750 O
18-Feb-21 15:21:16 1.78 723,485 Buy* 1.70 1.80 12.88k O
18-Feb-21 16:18:08 1.767 500,000 Buy* 1.70 1.80 8,835 O
18-Feb-21 16:16:32 1.769 169,250 Buy* 1.70 1.80 2,994 O
18-Feb-21 16:16:27 1.725 277,202 Sell* 1.70 1.80 4,782 O
18-Feb-21 16:16:18 1.725 412,914 Sell* 1.70 1.80 7,123 O
17-Feb-21 12:31:25 2.50 1,000,000 Buy* 1.70 1.80 25.00k O
17-Feb-21 15:14:08 2.5575 1,055,718 Buy* 1.70 1.80 27.00k O
17-Feb-21 10:38:22 2.5516 1,567,369 Buy* 1.70 1.80 39.99k O
17-Feb-21 09:41:21 2.55 1,000,000 Buy* 1.70 1.80 25.50k O
17-Feb-21 08:05:08 2.536 980,209 Buy* 1.70 1.80 24.86k O
17-Feb-21 10:42:55 2.57 1,478,326 Buy* 1.70 1.80 37.99k O
17-Feb-21 10:16:24 2.46 1,054,063 Buy* 1.70 1.80 25.93k O
17-Feb-21 09:46:23 2.4884 1,000,000 Buy* 1.70 1.80 24.88k O
17-Feb-21 09:45:30 2.55 900,000 Buy* 1.70 1.80 22.95k O
17-Feb-21 12:38:34 2.5283 1,200,000 Buy* 1.70 1.80 30.34k O
17-Feb-21 14:48:34 2.50 1,000,000 Buy* 1.70 1.80 25.00k O
18-Feb-21 16:13:32 1.76 624,233 Buy* 1.70 1.80 10.99k O
18-Feb-21 16:13:16 1.76 567,673 Buy* 1.70 1.80 9,991 O
18-Feb-21 16:12:52 1.76 397,187 Buy* 1.70 1.80 6,990

This news and market manipulation have been done today by The xx corrupt BOD to get the cheap shares.

I wouldn't be surprised if they release some good news next week.

I'm hoping on Dr cave to deliver now that the fighting has stopped.

This gives the new management opportunity to work on the best strategy to deliver shareholder value.

Remember DR Cave is a large shareholder & it is in his interest to deliver great results.

Please let me know to all the bedwetters that need nappies.

To achieve the EN14683 standard, the mask had to pass five tests, as follows:

Bacterial Filtration Efficiency (BFE): this tests the filtration capacity of the mask. The P2F product achieved a 98.77%; higher than the 98% required and close to the 99% needed for FFP3 respirator.

Differential Pressure: this tests the breathability of the mask. The maximum limit to obtain Type IIR is 2. The P2F mask achieved 46.4pa/cm2 which provides a good balance of breathability and BFE.

Splash resistance: this tests the resistance of the mask to penetration by blood fluid at 16kPa. It is the only required for Type IIR (differentiating it from Type II) as this type of mask can be used in a surgical setting. The key to passing the test is to have a hydrophobic outer layer on the mask. 100% of the masks in P2F sample passed this test compared to the minimum 90% pass rate requirement.

Microbiological cleanliness: this measures the quantity of microorganisms on the mask, effectively, checking the cleanliness of the manufacturing environment. The P2F masks passed, coming in below the maximum permitted measure of 30 cfu/g (Note: CFU is a microbiological measure for the number of viable cells in a sample).

This news and market manipulation have been done today by The xx corrupt BOD to get the cheap shares.

I wouldn't be surprised if they release some good news next week.

I'm hoping on Dr cave to deliver now that the fighting has stopped.

This gives the new management opportunity to work on the best strategy to deliver shareholder value.

Remember DR Cave is a large shareholder & it is in his interest to deliver great results.